3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Immunoglobulin Light-chain Amyloidosis
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Polycystic Ovary Syndrome
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hyperandrogenism
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Amyloidosis, Familial
1
Advanced Malignant Neoplasm
1
AA amyloidosis
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Doxycycline
×
Clear all
No trials found.